Nizatidine
Back to searchMolecule Structure
Scientific Name
Nizatidine
Description of the Drug
Nizatidine is an H2 receptor antagonist used to treat GERD and a variety of ulcers.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00585
http://www.drugbank.ca/drugs/DB00585
Brand Name(s)
Axid, Axid ar, Nizatidine, Zinga 150, Zinga 300
Company Owner(s)
Braintree Laboratories Inc, Apotex Inc, Glenmark Generics Inc Usa, Glaxosmithkline Consumer Healthcare Holdings Us Llc, Smithkline Beecham Corp Dba Glaxosmithkline, Watson Laboratories Inc, Epic Pharma Inc, Mylan Pharmaceuticals Inc., Amneal Pharmaceuticals, Ani Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Histamine H2 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL1941 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL770 | ||
| Human Metabolome Database | HMDB0259636 | ||
| DrugBank | DB00585 | ||
| PubChem | 4513 | ||
| Mcule | MCULE-2060254827 | ||
| LINCS | LSM-3031 | ||
| EPA CompTox Dashboard | DTXSID5023376 | ||
| DrugCentral | 1955 | ||
| rxnorm | AXID | AXID AR | NIZATIDINE |
| ChEBI | 7601 |
